VYNE Therapeutics Inc. Common Stock

VYNE XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

23M

Short interest (May 15)

0.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.27%

↓ 8.4%

Available Shares

↑ 10.2%

Price Chart

Company Overview

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001566044

Asset Type: CS

Market Data

Market Cap: $22,546,532

Employees: 10

Status: Active

Short Interest

Current Borrow Fee 0.27%

Range: 0.27% - 0.27%

Available Shares 5M

Range: 4.2M - 5M

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 1.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime